Jade Biosciences (JBIO) Earnings Analysis

Jade Biosciences (JBIO) next reports earnings on 2026-08-12, consensus EPS -0.66 USD. Last quarter (2026-05-07) it missed with EPS -0.57 USD vs -0.52 USD est (-9.6%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -6.80.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does JBIO next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate-0.66 USD
Revenue estimaten/a

JBIO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-0.57 USD-0.52 USD-9.6%Miss
2026-03-06-0.11 USD-0.45 USD+75.6%Beat
2025-11-13-0.48 USD-0.57 USD+15.8%Beat
2025-08-13-0.86 USD-0.43 USD-100%Miss
2025-04-25-0.09 USD-8.4 USD+98.9%Beat

Beat rate: 3/5 (60%) over reported quarters with consensus data.

JBIO valuation and analyst view

Trailing P/E-6.80
Trailing EPS-2.24326 USD
Price / book3.87
Dividend yield0.00%
Market cap0.64B
Analyst consensusBuy (4 buy / 0 hold / 0 sell)
Avg price target43 USD

Related research pages

Frequently asked questions

When is Jade Biosciences (JBIO)'s next earnings date?

Jade Biosciences is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.66 USD.

Did JBIO beat earnings last quarter?

In its 2026-05-07 report, JBIO posted EPS of -0.57 USD versus a -0.52 USD estimate — a miss of 9.6%.

What is JBIO's earnings track record?

Over the last 5 reported quarters with consensus data, JBIO beat estimates 3 times (60%).

What is JBIO's current P/E ratio and EPS?

JBIO trades at a trailing P/E of -6.80 on trailing EPS of -2.2432564837682847 USD.

What do analysts rate JBIO?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 43 USD.